society of neuroscience : NPR

Wednesday December 21, 2022

Brain Scientists Are Tripping Out Over Psychedelics

The active chemical in psylocibe cubensis (the "magic mushrooms" shown here) is being studied closely for its potential therapeutic benefits. labuda/Getty Images hide caption

toggle caption

labuda/Getty Images

Short Wave

Brain Scientists Are Tripping Out Over Psychedelics

December 21, 2022 • Psychedelic drugs – like LSD, salvia, ayahuasca, Ibogaine, MDMA (AKA ecstasy), or psilocybin (AKA 'magic mushrooms' or 'shrooms') – are experiencing a resurgence of interest in their potential medical benefits.

Brain Scientists Are Tripping Out Over Psychedelics

Listen · 11:05 11:05

Transcript

Download
Embed <iframe src="https://www.npr.org/player/embed/1144306776/1200393278" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Transcript